Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

DXCM PEER ANALYSIS

DexCom Inc — metric-by-metric comparison with peers and the industry median

DXCMDexCom Inc

🇺🇸 USA · US · Healthcare · Medical Devices

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial Health
DXCMIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
DXCM-14.8%PHIA+24.5%SHL-23.7%COH-57.7%4DX+1,670.8%
Year-to-Date (YTD)
DXCM+7.4%PHIA+10.3%SHL-20.3%COH-51.5%4DX+8.1%
1-Year
Split-adjusted
DXCM-14.8%GEHC-13.7%STE-7.4%ZBH-5.7%EW+22.5%PEN+27.6%
Year-to-Date (YTD)
DXCM+7.4%GEHC-20.0%STE-13.5%ZBH-2.5%EW+10.7%PEN+2.5%

Key Metric Comparison

P/E

Lower is better
DXCM30.14PHIA24.65SHL18.77COH23.724DX—Median 27.44

ROE

Higher is better
DXCM35.6%PHIA8.4%SHL11.4%COH18.1%4DX—Median -8.6%

Net Margin

Higher is better
DXCM19.3%PHIA5.5%SHL9.1%COH14.6%4DX-3,684.6%Median -5.7%

Revenue Growth

Higher is better
DXCM16.1%PHIA-1.9%SHL-0.3%COH2.0%4DX-26.0%Median 7.4%

P/E

Lower is better
DXCM30.14GEHC19.91STE27.44ZBH22.50EW50.15PEN73.65Median 27.44

ROE

Higher is better
DXCM35.6%GEHC15.2%STE11.3%ZBH6.1%EW10.7%PEN12.7%Median -8.6%

Net Margin

Higher is better
DXCM19.3%GEHC7.5%STE13.2%ZBH9.1%EW17.3%PEN11.8%Median -5.7%

Revenue Growth

Higher is better
DXCM16.1%GEHC0.8%STE8.7%ZBH9.2%EW13.8%PEN17.3%Median 7.4%

All Metrics

Valuation
MetricDXCMPHIASHLCOH4DXInd. Median
P/E30.1424.6518.77●23.72—27.44
P/B9.482.102.164.23-74.16●2.48
EV/EBITDA18.3010.82●11.9714.87—15.23
P/S5.821.36●1.703.47243.162.66
Financial Health
MetricDXCMPHIASHLCOH4DXInd. Median
Current Ratio1.951.321.102.466.57●3.28
Debt/Equity46.8%71.1%84.1%22.1%-22.6%●44.7%
NetDebt/EBITDA-0.70●2.033.040.420.710.82
Profitability
MetricDXCMPHIASHLCOH4DXInd. Median
Net Margin19.3%●5.5%9.1%14.6%-3,684.6%-5.7%
ROE35.6%●8.4%11.4%18.1%—-8.6%
ROA13.9%●3.6%4.6%12.4%-264.3%-6.4%
EBITDA Margin30.6%●15.4%19.1%24.0%-818.8%5.2%
Growth + Dividend
MetricDXCMPHIASHLCOH4DXInd. Median
Rev. Growth16.1%●-1.9%-0.3%2.0%-26.0%7.4%
NI Growth73.8%160.1%●0.3%-6.8%—16.7%
Div. Yield—3.5%2.9%3.6%●—1.1%
Payout—33.8%48.4%81.5%—39.0%
Valuation
MetricDXCMGEHCSTEZBHEWPENInd. Median
P/E30.1419.91●27.4422.5050.1573.6527.44
P/B9.482.812.991.35●5.318.552.48
EV/EBITDA18.3011.2612.6510.96●36.4856.9015.23
P/S5.821.50●3.622.048.698.662.66
Financial Health
MetricDXCMGEHCSTEZBHEWPENInd. Median
Current Ratio1.951.172.091.734.426.02●3.28
Debt/Equity46.8%99.1%29.1%59.0%6.8%●14.7%44.7%
NetDebt/EBITDA-0.702.440.903.19-2.09●-0.110.82
Profitability
MetricDXCMGEHCSTEZBHEWPENInd. Median
Net Margin19.3%●7.5%13.2%9.1%17.3%11.8%-5.7%
ROE35.6%●15.2%11.3%6.1%10.7%12.7%-8.6%
ROA13.9%●4.3%7.5%3.4%8.3%9.8%-6.4%
EBITDA Margin30.6%17.0%30.8%●26.2%22.5%15.2%5.2%
Growth + Dividend
MetricDXCMGEHCSTEZBHEWPENInd. Median
Rev. Growth16.1%0.8%8.7%9.2%13.8%17.3%●7.4%
NI Growth73.8%-31.1%27.3%-16.7%-73.8%305.0%●16.7%
Div. Yield—0.2%1.2%●1.1%——1.1%
Payout—4.3%30.9%24.9%——39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on DXCM

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.